4.6 Review

Therapeutic Trends of Cerebrovascular Disease during the COVID-19 Pandemic and Future Perspectives

期刊

JOURNAL OF STROKE
卷 24, 期 2, 页码 179-188

出版社

KOREAN STROKE SOC
DOI: 10.5853/jos.2022.00843

关键词

COVID-19; Stroke; Intracranial hemorrhages; Outcomes research; Epidemiology

资金

  1. Society of Vascular and Interventional Neurology

向作者/读者索取更多资源

This narrative review summarizes the changing paradigms and latest data regarding the complex relationship between COVID-19 and cerebrovascular disease. Despite the association between COVID-19 and thrombotic complications, global declines in ischemic stroke and other cerebrovascular diseases have been observed, which may be attributed to patient avoidance of healthcare institutions and declines in other transmissible infectious illnesses.
As of May 2022, there have been more than 400 million cases (including re-infections) of the systemic acute respiratory syndrome-coronavirus 2 (SARS-CoV-2), and nearly 5 million deaths worldwide. Not only has the coronavirus disease 2019 (COVID-19) pandemic been responsible for diagnosis and treatment delays of a wide variety of conditions, and overwhelmed the allocation of healthcare resources, it has impacted the epidemiology and management of cerebrovascular disease. In this narrative review, we summarize the changing paradigms and latest data regarding the complex relationship between COVID-19 and cerebrovascular disease. Paradoxically, although SARS-CoV-2 has been associated with many thrombotic complications???including ischemic stroke???there have been global declines in ischemic stroke and other cerebrovascular diseases. These epidemiologic shifts may be attributed to patient avoidance of healthcare institutions due to fear of contracting the novel human coronavirus, and also related to declines in other transmissible infectious illnesses which may trigger ischemic stroke. Despite the association between SARS-CoV-2 and thrombotic events, there are inconsistent data regarding targeted antithrombotics to prevent venous and arterial events. In addition, we provide recommendations for the conduct of stroke research and clinical trial planning during the ongoing COVID-19 pandemic, and for future healthcare crises.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据